FindTrial
Sign In

s acellular Pertussis vaccine given intramuscularly as a single dose on Day 0,BNA&#39

2 trials

Sponsors

BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Rd., Prakanong, Bangkok 10260 Thailand, BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Road, Prakanong, Bangkok 10260, Thailand

Conditions

Pertussis Whooping cough acellular Pertussis TdaPPertussis acellular pertussis vaccine (aP) and Tetanus Toxoid&#44

Phase 1

A phase I/II randomized, observer-blind, controlled study to assess safety and immunogenicity of acellular Pertussis vaccine given alone or in combination with Tetanus-diphtheria vaccine in healthy adults aged 18-35 years
Active, not recruitingTCTR20140703001
BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Rd., Prakanong, Bangkok 10260 ThailandPertussis Whooping cough acellular Pertussis TdaP
Start: 2014-06-28Updated: 2026-03-30

Phase 2

A phase II/III randomized, observer-blind, controlled study to demonstrate non-inferior immunogenicity of a combined Tetanus-diphtheria-acellular Pertussis vaccine as compared to Adacel® vaccine in healthy subjects aged 12-17 years
Active, not recruitingTCTR20150703002
BioNet-Asia Co., Ltd. 19 Soi Udomsuk 37, Sukhumvit 103 Road, Prakanong, Bangkok 10260, ThailandPertussis acellular pertussis vaccine (aP) and Tetanus Toxoid&#44
Start: 2015-07-06Updated: 2026-03-30

Related Papers

Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.
2018-09-2526 citations
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
2017-10-2023 citations